Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.
- DOI
- 10.1038/s41375-026-03105-y
- Published
- 2026 Aug 31
- Container
- Leukemia
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41375-026-03105-y,
title = {Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.},
author = {Moser LM and Hutter M and Ahlmann M and Alonso-Saladrigues A and Attarbaschi A and Ayuk FA and Baldus CD and Balduzzi A and Bonig H and Bourquin JP and Buechner J and Buecklein VL and Burridge S and Calkoen FG and Cario G and De Moerloose B and de Oliveira Canedo G and Dourthe ME and Feuchtinger T and Füreder A and Hauer J and Ifversen M and Jarisch A and Kalwak K and Klusmann JH and Kobbe G and Koenecke C and Künkele A and Meisel R and Merli P and Mielcarek-Siedziuk M and Müller F and Müller I and Napolitano S and Espuelas MO and Penack O and Rabian F and Rossig C and Sauer MG and Schlegel PG and von Stackelberg A and Strahm B and Willier S and Bader P and Rives S and Boissel N and Locatelli F and Ghorashian S and Baruchel A},
year = {2026},
journal = {Leukemia},
doi = {10.1038/s41375-026-03105-y},
url = {https://doi.org/10.1038/s41375-026-03105-y}
}RIS
TY - JOUR TI - Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome. AU - Moser LM AU - Hutter M AU - Ahlmann M AU - Alonso-Saladrigues A AU - Attarbaschi A AU - Ayuk FA AU - Baldus CD AU - Balduzzi A AU - Bonig H AU - Bourquin JP AU - Buechner J AU - Buecklein VL AU - Burridge S AU - Calkoen FG AU - Cario G AU - De Moerloose B AU - de Oliveira Canedo G AU - Dourthe ME AU - Feuchtinger T AU - Füreder A AU - Hauer J AU - Ifversen M AU - Jarisch A AU - Kalwak K AU - Klusmann JH AU - Kobbe G AU - Koenecke C AU - Künkele A AU - Meisel R AU - Merli P AU - Mielcarek-Siedziuk M AU - Müller F AU - Müller I AU - Napolitano S AU - Espuelas MO AU - Penack O AU - Rabian F AU - Rossig C AU - Sauer MG AU - Schlegel PG AU - von Stackelberg A AU - Strahm B AU - Willier S AU - Bader P AU - Rives S AU - Boissel N AU - Locatelli F AU - Ghorashian S AU - Baruchel A PY - 2026 JO - Leukemia DO - 10.1038/s41375-026-03105-y UR - https://doi.org/10.1038/s41375-026-03105-y ER -
APA
LM, M., M, H., M, A., A, A., A, A., FA, A., CD, B., A, B., H, B., JP, B., J, B., VL, B., S, B., FG, C., G, C., B, D. M., G, D. O. C., ME, D., T, F., A, F., J, H., M, I., A, J., K, K., JH, K., G, K., C, K., A, K., R, M., P, M., M, M., F, M., I, M., S, N., MO, E., O, P., F, R., C, R., MG, S., PG, S., A, V. S., B, S., S, W., P, B., S, R., N, B., F, L., S, G., & A, B. (2026). Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.. Leukemia. https://doi.org/10.1038/s41375-026-03105-y
Source records
- pubmed · retrieved 2026-09-25T23:04:41.944Z